National Health Investors, Inc.

National Health Investors, Inc. (NHI) Market Cap

National Health Investors, Inc. has a market capitalization of .

No quote data available.

CEO: D. Eric Mendelsohn

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1991-10-09

Website: https://www.nhireit.com

National Health Investors, Inc. (NHI) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Analyst Sentiment

71%
Buy

From 8 Active Polls

1Y Forecast: $84.75

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$83

Median

$85

High Bound

$86

Average

$85

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$84.75
▲ +20.33% Upside
Low Target
$83.00
18% Risk
Median Target
$85.00
21% Mid
High Target
$86.00
22% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 NATIONAL HEALTH INVESTORS REIT INC (NHI) — Investment Overview

🧩 Business Model Overview

NATIONAL HEALTH INVESTORS REIT INC (“NHI”) is a healthcare-focused REIT that owns and finances long-duration healthcare real estate and leases the properties to operating healthcare providers. The operating partner delivers care and manages day-to-day operations (staffing, clinical workflows, compliance), while NHI earns contracted rent through net-leased structures that typically pass through or largely control operating/property-level expenses. This design converts a portion of healthcare demand risk into more property-level cash flow characteristics through lease duration, underwriting, and rent structures—supporting the REIT’s ability to generate stable distributable cash flow if tenants remain solvent and facilities remain in use.

💰 Revenue Streams & Monetisation Model

NHI’s monetisation is primarily rental-based and driven by:
  • Base rent under long-term leases (recurring cash flow profile).
  • Rent escalators that can add inflation linkage and help protect real cash flow over time, depending on lease terms.
  • Pass-through components (e.g., property taxes, insurance, and certain operating costs, depending on contract structure), which can reduce margin volatility for the REIT.
Margin drivers are less about discretionary revenue growth and more about portfolio occupancy, tenant credit quality, lease coverage, and the durability of demand for the underlying care settings. Because the REIT’s income stream is real estate contractual cash flow, the most important determinant of distributable performance is whether tenant revenue can reliably support lease obligations—especially in environments where government reimbursement and labor costs change.

🧠 Competitive Advantages & Market Positioning

NHI’s competitive positioning is best understood as a specialised healthcare real estate underwriting and portfolio management advantage, reinforced by the practical constraints in healthcare facility supply. Moat thesis (hard-to-replicate advantages):
  • High barriers to entry in healthcare facility rollouts: building, licensing, and operationalizing post-acute and senior care capacity entails complex regulation, permitting, and reimbursement-aware design. New supply is not frictionless, limiting “fast competitor” entry.
  • Tenant relationship depth and credit underwriting: the REIT’s performance depends on tenant solvency and lease compliance, making disciplined capital allocation and recurring operator engagement a structural differentiator.
  • Lease-based customer stickiness: operator switching is costly because care delivery operations require facility-specific staffing patterns, operational readiness, and regulatory/clinical continuity. Once integrated, lease terms and operational complexity reduce short-cycle churn.
Competitive benchmarking:
  • Omega Healthcare Investors (OHI): also concentrated in skilled nursing and senior housing-related real estate. NHI competes most directly where lease structures, tenant selection, and reimbursement exposure overlap, but NHI’s differentiation comes from its specific facility mix and underwriting approach.
  • Welltower (WELL): broader senior housing and post-acute exposure, often with different mix and lease structures that can diversify outcomes but may shift risk characteristics across the care continuum.
  • Healthpeak (PEAK) (medical offices) and/or Ventas (VTR) (healthcare real estate): these focus more on medical office/life science or different healthcare property categories. Compared with these rivals, NHI’s positioning is more directly tied to long-duration demand for post-acute and skilled care settings rather than clinic/operator models.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the core growth opportunity is anchored in structural demand for post-acute and senior care capacity rather than a reliance on aggressive new-leasing growth:
  • Demographic-driven demand: aging populations expand the addressable pool for assisted and skilled care settings.
  • Inelastic capacity needs: healthcare facilities for the elderly are not substitutable in the short run, supporting long-lived utilization assumptions.
  • Continuing shift toward managed and value-based care dynamics: reimbursement and care delivery models influence utilization patterns and operational economics, but they generally maintain demand for appropriately licensed and staffed facilities.
  • Supply constraints: healthcare real estate development is capital intensive and subject to regulatory constraints, limiting rapid oversupply in many markets.
  • Capital recycling and portfolio optimization: REITs in this category can compound returns through selective acquisitions, targeted renovations/capex, and disciplined lease term management when opportunities arise.

⚠ Risk Factors to Monitor

Key structural risks include:
  • Reimbursement and regulatory changes: changes in Medicare/Medicaid payment formulas, eligibility, and compliance requirements can pressure tenant economics and lease coverage.
  • Tenant credit risk and lease performance: because rent is dependent on operating cash flows, operator distress can translate into rent disruptions, restructuring, or higher concessions.
  • Labor and operating cost inflation: staffing availability and wage growth can compress tenant margins, increasing the probability of covenant strain.
  • Capital intensity and property-level obligations: healthcare facilities often require ongoing maintenance and periodic upgrades to remain viable and compliant.
  • Financing and interest rate environment: higher borrowing costs can pressure growth and dividend sustainability depending on refinancing needs and leverage strategy.

📊 Valuation & Market View

Healthcare REIT valuation typically centers on cash flow durability rather than near-term accounting earnings. Market participants often focus on:
  • AFFO/FFO-style metrics (or cash flow equivalents), reflecting depreciation add-backs and recurring distributable capacity.
  • Lease-level fundamentals: occupancy, coverage, rent escalator characteristics, lease term laddering, and re-leasing risk.
  • Real estate yield and cap-rate expectations: comparable property yields and interest rate expectations influence implied asset values.
What moves the needle most consistently is the perceived stability of distributable cash flow—driven by tenant credit and lease performance—and how capital markets price the REIT’s refinancing and interest rate risk.

🔍 Investment Takeaway

NHI’s long-term investment case is grounded in a specialised, lease-driven healthcare real estate model that benefits from demand persistence for post-acute and senior care settings and from structural barriers that slow new supply. The primary analytical focus should remain on tenant credit quality, reimbursement exposure, lease structure durability, and disciplined capital allocation, since those factors determine whether contractual cash flows translate into reliable distributable earnings over the full cycle.

⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"NHI reported Q1’26 revenue of $115.1M and net income of $40.0M (EPS $0.83). On a QoQ basis, revenue rose to 115.1M from $106.5M in Q4’25 (+8.1%), and net income increased to $40.0M from $38.2M (+4.8%). YoY, revenue grew from $89.3M in Q1’25 (+28.9%) and net income rose from $34.2M (+17.1%), with EPS moving from $0.75 to $0.83 (+10.7% YoY). Profitability: net margin was 34.8% in Q1’26 versus 35.8% in Q4’25 (mild contraction QoQ) and 38.3% in Q1’25 (down YoY). Operating income was $0.04M in Q1’26, down from $50.2M in Q4’25, indicating elevated non-operating/other line impacts this quarter. Cash flow and shareholder returns: Q1’26 operating cash flow was $53.4M and free cash flow was $53.4M. The company paid $44.4M in dividends, and there were no buybacks reported in the quarter; dividend payout looks heavy (payout ratios above 100% on the provided ratios), though cash generation remained positive. Total shareholder value is supported by price momentum (+13.7% 1Y) and a dividend yield around ~1.1%. Balance sheet: leverage appears moderate-to-low for a non-bank, with total assets $2.89B and equity about $1.52B in Q1’26; net debt is negative (net cash position) at -$25M."

Revenue Growth

Good

QoQ revenue +8.1% (115.1M vs 106.5M) and YoY +28.9% (115.1M vs 89.3M), showing strong top-line acceleration.

Profitability

Fair

Net margin contracted QoQ (34.8% vs 35.8%) and YoY (34.8% vs 38.3%). EPS rose YoY (+10.7%) but operating income fell sharply vs Q4’25.

Cash Flow Quality

Positive

Operating cash flow $53.4M and free cash flow $53.4M in Q1’26. Dividends paid were significant ($44.4M); payout ratios in the dataset exceed 100%, but coverage still appears supported by OCF.

Leverage & Balance Sheet

Positive

Q1’26 total assets $2.89B with equity ~$1.52B. Net debt is negative (-$25M), suggesting a resilient liquidity position.

Shareholder Returns

Neutral

Total shareholder support from price appreciation (+13.7% 1Y) plus dividends (~1.1% yield). No buybacks reported in Q1’26.

Analyst Sentiment & Valuation

Neutral

Consensus target $85.4 vs current price $85.65 implies near-even valuation vs Street expectations; upside/downside looks limited.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

NHI started 2026 with Q1 results ahead of internal expectations across NAREIT FFO, normalized FFO, and FAD, supported by strong SHOP scaling and better-than-guided NHC percentage rent outcomes (including a $1.3M cash rent benefit vs February expectations). However, management’s updated 2026 outlook is pressured by the timing of a $560M NHC disposition, creating near-term earnings drag despite the balance-sheet liquidity upgrade. The portfolio shift is the core strategic move: pro forma SHOP rises to ~24% of the portfolio and private pay senior housing exposure to ~80% of annualized NOI, supported by a $212.4M YTD SHOP investment pace (>100% capital growth YoY) and a new Colorado deal yielding ~8.3% initially (7.8% after CapEx). Risks center on Holiday same-store NOI (reset to 1%–3%) driven by isolated census loss and delayed CapEx lease-ups, plus market tightening affecting achievable incremental yields (~7% year 1).

AI IconGrowth Catalysts

  • SHOP scaling: Total SHOP NOI increased 188.1% vs. Q1 2025 driven by transition/acquisition of 20 properties
  • Colorado SHOP acquisition closed May 1 (7 properties, 532 units) tracking ahead of initial expectations
  • Updated full-year SHOP same-store NOI growth reset to 1%–3% due to Holiday underperformance; non-same-store contribution increased vs prior forecast
  • Triple-net portfolio stability: no rent concessions; steady occupancy and EBITDARM coverage
  • Bickford lease reset to fair market value (April 1) with base rent $38.4M (+$3.2M vs prior) and 2%–3% annual escalators; conditional rent extends lease upside

Business Development

  • NHC portfolio sale agreement for $560 million (capital recycling; concentration shift to private pay senior housing)
  • Colorado 7-property SHOP acquisition (closed May 1): management transitions to Generations (existing lessee in Colorado)
  • Asset dispositions: 4 properties with 4 operators for net proceeds ~$53.4M
  • Additional dispositions under contract: 3 properties for expected net proceeds ~$58M
  • Pipeline: $560M active pipeline; $20.3M under signed LOIs; $200M+ in outstanding LOIs for larger portfolio opportunities
  • Bickford: lease reset with operator (conditional rent formula similar to prior deferral-collection structure)

AI IconFinancial Highlights

  • EPS (GAAP net income per share): $0.82, +10.8% YoY
  • NAREIT FFO per share: $1.23, +7.9% YoY
  • Normalized FFO per share: increased 7% YoY to $1.23
  • FAD: $62.5M, +11.6% YoY
  • Q1 drivers: above-expectation NHC percentage revenue rent true-up; and larger-than-expected improvement in NHC percentage revenue rent yielding ~$1.3M higher cash rent vs Feb guidance
  • Cash G&A: $5.6M, +31% YoY due to ramping SHOP growth strategy
  • Interest expense: +4.9% YoY due to higher average debt interest rates
  • Cash/financing metrics: cash $24.9M; revolver capacity $391M; liquidity ~$960M excluding proceeds from future dispositions
  • Guidance update (full-year 2026): GAAP net income midpoint $14.37/share including significant gain from pending NHC lease portfolio disposition
  • FFO per share guidance midpoint: $4.77/share; +2.6% vs 2025 for NAREIT FFO; NFFO midpoint -2.9% vs 2025
  • FAD midpoint: $242.2M, +4.1%
  • Same-store SHOP NOI growth guidance reset to 1%–3%; expected FFO per share impact <1%
  • SHOP investment share: pro forma SHOP ~24% of total portfolio and >15% of annualized NOI after NHC and other asset sales; management expects that SHOP percentage to continue increasing as capital redeploys
  • SHOP pro forma investment mix contribution: NHC expected to increase shift to ~80% of annualized NOI toward private pay senior housing

AI IconCapital Funding

  • Dividend declared: $0.92/share (record June 30, 2026; payable Aug 7, 2026)
  • Capital recycling: pending NHC sale $560M; management expects initial >$200M proceeds to reduce debt
  • Liquidity/capital access: net debt/adjusted EBITDA 4x Q1; midpoint leverage policy 3.5x–4.5x; available liquidity excluding future disposition proceeds ~$960M
  • Revolver capacity: $391M; revolver maturity 2028; 2026 and 2027 debt maturities total $225M
  • ATM capacity restored: refreshed shelf registration and new equity ATM distribution agreements; ATM capacity returned to $500M
  • Forward equity: remaining escrowed forward equity proceeds ~$44.2M for future delivery of 643,000 common shares at avg ~$68.81/share
  • Investment cadence: closed $105.5M during Q1; total closed 2026 investments >$212M; full-year guidance includes $180M additional future investments
  • Guidance investment totals: $392M in new announced and unidentified 2026 investments at average NOI yield of 8%

AI IconStrategy & Ops

  • Capital recycling strategy accelerates concentration shift: pending NHC disposition accelerates private pay senior housing exposure to ~80% of annualized NOI
  • SHOP scaling emphasis: invested capital through Q1 increased >100% vs prior year; management adding technology and experienced hires to build asset management scale advantage
  • Holiday same-store performance evaluation: below-expectation due to isolated census loss in a handful of properties and delayed extensive CapEx lease-ups; considering strategic alternatives
  • Non-same-store framing: 11 non-same-store transitioned/acquired properties since Q1 last year contributed $4.3M NOI (5.2% sequential growth from Q4 2025); non-same-store SHOP estimated annualized NOI ~$33M representing 73% of total SHOP NOI
  • Bickford capital structure/lease mechanics updated April 1: conditional rent continues through lease; extends contingent rent eligibility ~5+ years; base rent increased $3.2M

AI IconMarket Outlook

  • Full-year 2026 same-store SHOP NOI growth guidance: 1% to 3%
  • Full-year 2026 NAREIT FFO per share midpoint: $4.77 (+2.6% vs 2025)
  • Full-year 2026 NFFO per share midpoint: down 2.9% vs 2025 (midpoint value not separately stated)
  • Full-year 2026 FAD midpoint: $242.2M (+4.1%)
  • Guidance NOI yields: average NOI yield 7.8% (comprised ~60% in SHOP for remainder of year); and $392M of new investments at average NOI yield 8%
  • Near-term return expectation for newer/SHOP acquisitions: high single-digit to low double-digit NOI growth; projected rates of return in low to mid-teens
  • SHOP incremental acquisition yield context from Q&A: year 1 yields ~7% (plus/minus); management hopes to do better but expects market-driven constraints

AI IconRisks & Headwinds

  • Near-term earnings pressure from timing of pending NHC sale and redeployment: capital recycling is expected to pull down guidance
  • Holiday same-store SHOP underperformance: localized census loss in a handful of properties and delayed CapEx projects impacting lease-up; guidance reset (but stated FFO per share impact <1%)
  • Cash G&A ramp and higher interest expense due to higher average interest rates
  • Liquidity/financing timing risk: capital market activity may adjust due to changing timing and amount of investments/dispositions
  • No assurance on pipeline conversion: large portfolio negotiations described as non-certain until closed
  • Market tightening and competitive pricing acknowledged; yields are market-constrained (~7% year 1) though management targets better outcomes

Q&A: Analyst Interest

  • Pipeline breakdown & structure: Management said the $560M pipeline is consistent and predominantly senior housing. They emphasized flexibility in assessing whether deals are best as leases vs SHOP with possible transition paths, and that SHOP is an emphasis, not yet quantified post-NHC.
  • NHC sale drag on FAD and reinvestment assumptions: Management explained the FAD decrease depends on proceed handling and timing, including reverse 1031 proceeds locked for intermediary timeframes. They reiterated the $180M additional investment is an incremental guidance increase, still conservative, with outperformance offsetting some NHC pull-down.
  • Holiday underperformance drivers & remediation: Management said modest seasonality exists, but the issue is isolated to a handful of Holiday properties with census loss and delays in extensive CapEx projects, pushing lease-up. They reset expectations to avoid later-year adjustments and characterized outlook as manageable despite disappointing results.

Sentiment: MIXED

Note: This summary was synthesized by AI from the NHI Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — National Health Investors, Inc. (NHI) Financial Profile